Organon (OGN) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Organon Revenue Highlights


Latest Revenue (Y)

$6.26B

Latest Revenue (Q)

$1.58B

Main Geography (Y)

Europe and Canada

Organon Revenue by Period


Organon Revenue by Year

DateRevenueChange
2023-12-31$6.26B1.44%
2022-12-31$6.17B-2.06%
2021-12-31$6.30B-22.13%
2020-12-31$8.10B4.10%
2019-12-31$7.78B-20.46%
2018-12-31$9.78B-

Organon generated $6.26B in revenue during NA 2023, up 1.44% compared to the previous quarter, and up 64.06% compared to the same period a year ago.

Organon Revenue by Quarter

DateRevenueChange
2024-09-30$1.58B-1.56%
2024-06-30$1.61B-0.92%
2024-03-31$1.62B1.50%
2023-12-31$1.60B5.20%
2023-09-30$1.52B-5.53%
2023-06-30$1.61B4.55%
2023-03-31$1.54B3.57%
2022-12-31$1.49B-3.38%
2022-09-30$1.54B-3.03%
2022-06-30$1.58B1.15%
2022-03-31$1.57B-2.31%
2021-12-31$1.60B0.25%
2021-09-30$1.60B0.31%
2021-06-30$1.59B5.91%
2021-03-31$1.51B-52.60%
2020-12-31$3.18B96.96%
2020-09-30$1.61B5.70%
2020-06-30$1.53B-14.27%
2020-03-31$1.78B-

Organon generated $1.58B in revenue during Q3 2024, up -1.56% compared to the previous quarter, and up 98.38% compared to the same period a year ago.

Organon Revenue Breakdown


Organon Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
Europe and Canada$1.67B$1.63B$1.74B
CHINA$864.00M$917.00M$933.00M
Asia Pacific and Japan$1.13B$1.14B$1.17B
UNITED STATES$1.48B--
Other Countries$154.00M$151.00M$233.00M
Latin America, Middle East, Russia and Africa$965.00M$895.00M$841.00M

Organon's latest annual revenue breakdown by geography, as of Dec 23: Europe and Canada (26.71%), UNITED STATES (23.60%), Asia Pacific and Japan (18.03%), Latin America, Middle East, Russia and Africa (15.41%), CHINA (13.80%), and Other Countries (2.46%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
CHINA$212.00M$206.00M$203.00M$202.00M$234.00M$225.00M$196.00M$241.00M$244.00M$236.00M$240.00M$252.00M$236.00M$205.00M
Latin America, Middle East, Russia And Africa$243.00M-------------
Europe And Canada$436.00M-------------
Asia Pacific and Japan$260.00M$287.00M$260.00M$284.00M$261.00M$324.00M$255.00M$283.00M$291.00M$314.00M$299.00M$287.00M$309.00M$285.00M
Other Countries$33.00M$34.00M$32.00M$32.00M$41.00M$49.00M$22.00M$48.00M$40.00M$43.00M$43.00M$67.00M$51.00M$-28.00M
UNITED STATES$398.00M$371.00M$1.11B$370.00M----------
Europe and Canada-$450.00M$414.00M$392.00M$467.00M$400.00M$388.00M$363.00M$443.00M$436.00M$427.00M$410.00M$470.00M$490.00M
Latin America, Middle East, Russia and Africa-$274.00M$278.00M$239.00M$234.00M$214.00M$230.00M$236.00M$216.00M$209.00M$246.00M$238.00M$190.00M$203.00M

Organon's latest quarterly revenue breakdown by geography, as of Sep 24: Europe And Canada (27.56%), UNITED STATES (25.16%), Asia Pacific and Japan (16.43%), Latin America, Middle East, Russia And Africa (15.36%), CHINA (13.40%), and Other Countries (2.09%).

Organon Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
JNJJohnson & Johnson$85.15B$22.47B
MRKMerck$60.12B$16.11B
PFEPfizer$58.50B$13.28B
ABBVAbbVie$54.32B$14.46B
NVSNovartis$46.66B$11.83B
AZNAstraZeneca$45.81B$12.68B
BMYBristol-Myers Squibb Company$45.01B$11.89B
SNYSanofi$43.07B$11.12B
LLYEli Lilly and Company$34.12B$11.44B
AMGNAmgen$28.19B$8.50B
GILDGilead Sciences$27.12B$6.95B
BIIBBiogen$9.84B$2.47B
OGNOrganon$6.26B$1.58B

OGN Revenue FAQ


Organon's yearly revenue for 2023 was $6.26B, representing an increase of 1.44% compared to 2022. The company's yearly revenue for 2022 was $6.17B, representing a decrease of -2.06% compared to 2021. OGN's yearly revenue for 2021 was $6.3B, representing a decrease of -22.13% compared to 2020.

Organon's quarterly revenue for Q3 2024 was $1.58B, a -1.56% decrease from the previous quarter (Q2 2024), and a 4.15% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.61B, a -0.92% decrease from the previous quarter (Q1 2024), and a -0.06% decrease year-over-year (Q2 2023). OGN's quarterly revenue for Q1 2024 was $1.62B, a 1.50% increase from the previous quarter (Q4 2023), and a 5.46% increase year-over-year (Q1 2023).

Organon's revenue growth rate for the last 3 years (2021-2023) was -0.65%, and for the last 5 years (2019-2023) was -19.47%.